From May 2022 through December 2023 I worked with a pharma sponsor helping to enhance diversity in their clinical trials. Due to the contractual arrangement I was unable to post or blog or otherwise discuss the work I was doing. As a result, I have not posted here for...
This is the first of a series of posts planned over the next few weeks. At the end of April, I finally attended my first in-person industry meeting in two years. I had the honor of presenting at the DTC National meeting during the Multicultural Health track, held in...
So, has the FDA finally decided to use its power to ensure diversity in clinical trials? I say a resounding “YES!!!!”. FINALLY. The guidance issued April 14, 2022 has the teeth needed to push the industry to finally DO something. This guidance draws...
This is a commentary on “Why Poor Diversity in Medical Research Threatens Health Equity” first published on the Patient Engagement HIT website here. The article clearly recognizes the value of working with the community, however, there is more to say on...
I have long since learned that it is the community that influences people’s choices and behaviors. This article documents this, that the church has incredible influence on people’s decision-making. In light of COVID the world has learned there has to be a...
Finally, the guidance really starts to address the broad range of issues that challenge clinical trials to be more diverse. I am struck by the opening paragraph of the cover letter that Dr. Hahn attached to the release of this guidance: Throughout my career as a...
